Caliot, E., C. Libon, et al. (2000). "Translocation of ribosomal immunostimulant through an in vitro-reconstituted digestive barrier containing M-like cells." Scand J Immunol 52(6): 588-94.
Cella, M., M. Salio, et al. (1999). "Maturation, activation, and protection of dendritic cells induced by double-stranded RNA." J Exp Med 189(5): 821-9.
Dadaglio, G., S. Morel, et al. (2003). "Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes." Int Immunol 15(12): 1423-1430.
Dadaglio, G., Z. Moukrim, et al. (2000). "Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis." Infect Immun 68(7): 3867-72.
Fayolle, C., C. Bauche, et al. (2004). "Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo." Vaccine 23(5): 604-14.
Fayolle, C., D. Ladant, et al. (1999). "Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope." J Immunol 162(7): 4157-62.
Fayolle, C., A. Osickova, et al. (2001). "Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity." J Virol 75(16): 7330-8.
Fayolle, C., P. Sebo, et al. (1996). "In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes." J Immunol 156(12): 4697-706.
Guermonprez, P., C. Fayolle, et al. (2000). "Bordetella pertussis adenylate cyclase toxin: a vehicle to deliver CD8-positive T-cell epitopes into antigen-presenting cells." Methods Enzymol 326: 527-42.
Guermonprez, P., C. Fayolle, et al. (2002). "In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells." Eur J Immunol 32(11): 3071-81.
Guermonprez, P., N. Khelef, et al. (2001). "The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18)." J Exp Med 193(9): 1035-44.
Ladant, D. and A. Ullmann (1999). "Bordatella pertussis adenylate cyclase: a toxin with multiple talents." Trends Microbiol 7(4): 172-6.
Loucka, J., G. Schlecht, et al. (2002). "Delivery of a MalE CD4(+)-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase." Infect Immun 70(2): 1002-5.
Mascarell, L., C. Bauche, et al. (2006). "Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates." Vaccine 24(17):3490-9.
Mascarell, L., C. Fayolle, et al. (2005). "Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis." J Virol 79(15): 9872-84.
Preville, X., D. Ladant, et al. (2005). "Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein." Cancer Res 65(2): 641-9.
Puaux, A. L., J. Campanaud, et al. (2006). "A very rapid and simple assay based on trogocytosis to detect and measure specific T and B cell reactivity by flow cytometry." Eur J Immunol 36(3): 779-88.
Saron, M. F., C. Fayolle, et al. (1997). "Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus." Proc Natl Acad Sci U S A 94(7): 3314-9.
Schlecht, G., J. Loucka, et al. (2004). "Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming." J Immunol 173(10): 6089-97.
Wilkinson, K. A., M. Simsova, et al. (2005). "Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids." Infect Immun 73(5): 2991-8.
Yusupov, M. M., G. Z. Yusupova, et al. (2001). "Crystal structure of the ribosome at 5.5 A resolution." Science 292(5518): 883-96.
Zanin, C., P. Perrin, et al. (1994). "Antibody-producing cells in peripheral blood and tonsils after oral treatment of children with bacterial ribosomes." Int J Immunopharmacol 16(7): 497-505.